KDM5B demethylated H3K4me3 on the miR‐448 promoter and thereby inhibited the expression of miR‐448, which in turn targeted YTHDF3 and integrin subunit alpha 6 (ITGA6) to promote the malignant phenotype of HCC. Here, KDM5B is linked to hepatocellular carcinoma.